Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
The Lancet. Neurology
|
August 21, 2021
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
J William L Brown, Nick G Cunniffe, Ferran Prados, et al.
Radiology
|
February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection
Piet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosis
Veronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology
|
August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis
Sarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
The Lancet. Neurology
|
August 21, 2021
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
J William L Brown, Nick G Cunniffe, Ferran Prados, et al.
Radiology
|
February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection
Piet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosis
Veronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology
|
August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis
Sarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Page
of 8